Profound Medical Corp

NASDAQ:PROF 3:59:54 PM EDT

6.10

+0.20 (+3.42%)

6:42:35 PM EDT: $6.70 +0.60 (+9.80%)

Market Cap (Intraday)	183.38M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$3.25 Million
Adjusted EPS	-$0.37

See more estimates

10-Day MA	$6.13
50-Day MA	$5.40
200-Day MA	$6.70

See more pivots

Profound Medical Corp Stock, NASDAQ:PROF

2400 Skymark Avenue, Unit No. 6, Mississauga, Ontario L4W 5K5

Canada

Phone: +1.647.476.1350

Number of Employees: 142

http://www.profoundmedical.com

Description

Profound Medical Corp. is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the ablation of diseased tissue utilizing its platform technologies. The firmÃ¢â?¬â?¢s product, the TULSA-PRO system, combines real-time MRI, robotically driven transurethral sweeping action/thermal ultrasound, and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It is also focused on developing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases. The company was founded on June 13, 2008 and is headquartered in Mississauga, Canada.